Paul Harkin
Direktor/Vorstandsmitglied bei Almac Diagnostic Services Ltd.
Profil
Paul Harkin is currently a Director at Almac Diagnostic Services Ltd.
Aktive Positionen von Paul Harkin
Unternehmen | Position | Beginn |
---|---|---|
Almac Diagnostic Services Ltd.
Almac Diagnostic Services Ltd. Miscellaneous Commercial ServicesCommercial Services Part of The McClay Foundation, Almac Diagnostic Services Ltd. offers a complete range of peptide and protein services, from catalogue products to GMP manufacture, for early phase to commercial launch. The company is based in Craigavon, UK. Almac Group provides a range of contract pharmaceutical development and manufacturing services. Almac Interactive Response Technology (IRT) technologies suite offers 3 modes to configure your IXRS platform varying in levels of customizations, speed to go live, and costs for your clinical supply chain study. The British company is one of the leading, multi-faceted, solution providers within the niche and complex market of clinical trial supply. Almac Diagnostic Services was initially founded as a spin-out company from Queen's University in 2002 called Arradx, which was incorporated into the Almac Group in 2004. | Direktor/Vorstandsmitglied | - |
Erfahrungen
Besetzte Positionen
Aktive
Inaktive
Börsennotierte Unternehmen
Private Unternehmen
Beziehungen
Beziehungen ersten Grades
Unternehmen ersten Grades
Herr
Frau
Aufsichtsräte
Führungskräfte
Unternehmensverbindungen
Private Unternehmen | 1 |
---|---|
Almac Diagnostic Services Ltd.
Almac Diagnostic Services Ltd. Miscellaneous Commercial ServicesCommercial Services Part of The McClay Foundation, Almac Diagnostic Services Ltd. offers a complete range of peptide and protein services, from catalogue products to GMP manufacture, for early phase to commercial launch. The company is based in Craigavon, UK. Almac Group provides a range of contract pharmaceutical development and manufacturing services. Almac Interactive Response Technology (IRT) technologies suite offers 3 modes to configure your IXRS platform varying in levels of customizations, speed to go live, and costs for your clinical supply chain study. The British company is one of the leading, multi-faceted, solution providers within the niche and complex market of clinical trial supply. Almac Diagnostic Services was initially founded as a spin-out company from Queen's University in 2002 called Arradx, which was incorporated into the Almac Group in 2004. | Commercial Services |